Peter Heerma Travere Therapeutics, Inc. (TVTX) insider trading activity

Peter Heerma is CHIEF COMMERCIAL OFFICER of Travere Therapeutics, Inc.. Currently has a direct ownership of 99,503 shares of TVTX, which is worth approximately $975,129. The most recent transaction as insider was on Feb 01, 2024, when has been sold 4,195 shares (Common Stock) at a price of $8.53 per share, resulting in proceeds of $35,783. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 99.5K

0% 3M change

21.24% 12M change

Total Value Held $975,129

Peter Heerma Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 01 2024	SELL Open market or private sale	$35,783 $8.53 p/Share	4,195 Reduced 4.05%	99,503 Common Stock
Jan 31 2024	BUY Grant, award, or other acquisition	-	25,000 Added 19.43%	103,698 Common Stock
Jan 23 2024	SELL Open market or private sale	$14,140 $9.07 p/Share	1,559 Reduced 1.94%	78,698 Common Stock
Oct 03 2023	SELL Open market or private sale	$25,500 $8.25 p/Share	3,091 Reduced 3.71%	80,257 Common Stock
Feb 01 2023	SELL Open market or private sale	$38,693 $21.75 p/Share	1,779 Reduced 2.12%	82,069 Common Stock
Jan 31 2023	BUY Grant, award, or other acquisition	-	20,250 Added 19.45%	83,848 Common Stock
Jan 24 2023	SELL Open market or private sale	$33,945 $21.9 p/Share	1,550 Reduced 2.38%	63,598 Common Stock

Jan 31 2022	SELL Open market or private sale	$30,825 $27.4 p/Share	1,125 Reduced 1.64%	67,297 Common Stock
Jan 31 2022	BUY Grant, award, or other acquisition	-	9,840 Added 12.57%	68,422 Common Stock
Jan 24 2022	SELL Open market or private sale	$46,837 $24.98 p/Share	1,875 Reduced 3.1%	58,582 Common Stock
Oct 04 2021	SELL Open market or private sale	$75,747 $24.77 p/Share	3,058 Reduced 4.81%	60,457 Common Stock
Aug 17 2021	SELL Open market or private sale	$24,088 $17.12 p/Share	1,407 Reduced 2.17%	63,515 Common Stock
Aug 13 2021	BUY Grant, award, or other acquisition	-	4,500 Added 6.48%	64,922 Common Stock
Feb 08 2021	SELL Open market or private sale	$35,527 $31.58 p/Share	1,125 Reduced 1.86%	59,344 Common Stock
Feb 05 2021	SELL Open market or private sale	$35,336 $31.41 p/Share	1,125 Reduced 1.83%	60,469 Common Stock
Feb 03 2021	SELL Open market or private sale	$16,276 $28.91 p/Share	563 Reduced 0.98%	57,094 Common Stock
Feb 03 2021	BUY Grant, award, or other acquisition	-	4,500 Added 6.81%	61,594 Common Stock
Feb 02 2021	SELL Open market or private sale	$17,312 $30.75 p/Share	563 Reduced 0.97%	57,657 Common Stock
Jan 21 2021	BUY Grant, award, or other acquisition	-	15,000 Added 20.49%	58,220 Common Stock
Oct 05 2020	SELL Open market or private sale	$42,338 $19.35 p/Share	2,188 Reduced 4.91%	42,329 Common Stock
Oct 02 2020	SELL Open market or private sale	$41,353 $18.9 p/Share	2,188 Reduced 4.68%	44,517 Common Stock

Peter Heerma

CHIEF COMMERCIAL OFFICER

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TVTX shares.

Notify only if

Value

Insider Trading

Get notified when an Travere Therapeutics, Inc. insider buys or sells TVTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Travere Therapeutics, Inc.

Track Activities on TVTX

Account